IP Library Granted Patent US 7,879,103
Granted Patent B2
US 7,879,103 · App. 11/404,806 · Granted Feb 1, 2011

Vertebral disc repair

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,103
App. No.
11/404,806
Granted
Feb 1, 2011
Kind
B2
Abstract

A sterile implant for treatment of a spinal disc defect comprising an allograft cortical bone demineralized to a Type I collagen having a specific shape which is treated to eliminate osteoinductivity. The implant is lyophilized and compressed into smaller first shape which 20 to 80% from its original shape in at least one dimension and hardened. The implant expanding when hydrated into a second shape having the shape memory of the first shape and expanded in dimensional size from the first compressed shape.

Claims (45)

1. An implant for non-fusion repair of a defective vertebral disc which occupies a space between a superior vertebra and an inferior vertebra and which includes an annulus fibrosus having outer and inner walls and a nuclear cavity having a boundary bordered by the inner wall of the annulus fibrosus and by the superior and inferior vertebrae, said implant comprising: an exterior surface and a porous load-bearing body defining said exterior surface and having an original shape selected to at least partially fill the nuclear cavity of the defective vertebral disc, said body being formed from substantially demineralized, non-osteoinductive bone such that said body is deformable from its said original shape into a compressed shape that facilitates the insertion of said body into the nuclear cavity of the defective vertebral disc, said body having shape memory such that it assumes its said original shape in response to its exposure to fluid, said body being sized and shaped such that said exterior surface is engageable with a substantial portion of the boundary of the nuclear cavity of the defective vertebral disc when said body assumes its said original shape after insertion into the nuclear cavity of the defective vertebral disc, and wherein said body includes a first section made of cortical bone and a second section made of cancellous bone.

2. The implant of claim 1 , wherein said bone has a calcium content that does not exceed about 0.2% wt/wt.

3. The implant of claim 1 , wherein said original shape has at least one dimension that is reduced within a range of from 20% to 50% when said body is deformed into its said compressed shape.

4. The implant of claim 1 , wherein said original shape has at least one dimension that is reduced by more than 50% when said body is deformed into its said compressed shape.

5. The implant of claim 1 , wherein said body has a ring shape, said body including an annular exterior member and a hollow space within said exterior member, said exterior member collapsing when said body is in its said compressed shape to thereby collapse said hollow space.

6. The implant of claim 1 , wherein said first section has a ring shape and wherein said second section is positioned within said first section.

7. The implant of claim 1 , wherein said body has a cylindrical shape.

8. The implant of claim 1 , wherein said body has a spheroid shape.

9. The implant of claim 1 , wherein said body has a spiral shape.

10. The implant of claim 1 , wherein said body has an accordion shape.

11. The implant of claim 1 , wherein said body has a W shape.

12. The implant of claim 1 , wherein said body has a rectangular shape.

13. The implant of claim 1 , wherein said body includes at least one bioactive agent.

14. The implant of claim 13 , wherein said at least one bioactive agent includes one or more substances taken from a group consisting of growth factors, hormones, viral particles, platelet rich plasma, and naked DNA.

15. The implant of claim 14 , wherein said growth factors include TGFβ, FGF, VEGF, PDGF, EGF, HGF, IGF and IL superfamilies.

16. The implant of claim 13 , wherein said at least one bioactive agent is adsorbed to said body.

17. The implant of claim 13 , wherein said body includes a collagen backbone, said at least one bioactive agent being covalently bonded to said collagen backbone.

18. The implant of claim 13 , wherein said body is impregnated with said at least one bioactive agent.

19. The implant of claim 1 , wherein said body includes at least one tissue fragment.

20. The implant of claim 1 , wherein said body includes bone marrow aspirate.

21. The implant of claim 1 , wherein said body includes live cells.

22. The implant of claim 21 , wherein said live cells include disc cells.

23. The implant of claim 21 , wherein said live cells include marrow cells.

24. The implant of claim 21 , wherein said live cells include stroma cells.

25. The implant of claim 21 , wherein said live cells include mesenchymal cells.

26. The implant of claim 21 , wherein said live cells include chondrocytes.

27. The implant of claim 21 , wherein said live cells include autogenic stem cells.

28. The implant of claim 21 , wherein said live cells are adhered to a surface of said body.

29. The implant of claim 21 , wherein said body includes a collagen network, said collagen network being impregnated with said live cells.

30. The implant of claim 1 , wherein said body includes a radiopaque marker.

31. The implant of claim 1 , wherein said body includes a top face and a bottom face opposite said top face.

32. The implant of claim 31 , wherein said top face of said body has a lordotic curvature that conforms to the curvature of a vertebral end plate of the superior vertebra.

33. The implant of claim 31 , wherein said bottom face of said body has a lordotic curvature that conforms to the curvature of a vertebral end plate of the inferior vertebra.

34. The implant of claim 31 , wherein said body includes a plurality of holes, each of said holes having a diameter less than 1 mm and extending in an axial direction that is substantially perpendicular to said top face and said bottom face of said body.

35. The implant of claim 31 , wherein said body includes a plurality of holes, each of said holes having a diameter less than 1 mm and extending in a radial direction that is substantially parallel to said top face and said bottom face of said body.

36. The implant of claim 1 , wherein said body has a pH in range of from 6.6 to 7.4.

37. The implant of claim 1 , wherein said body assumes its said original shape in response to its exposure to a physiological fluid.

38. The implant of claim 1 , wherein the annulus fibrosus has a major axis and a minor axis, said body being sized and shaped such that said exterior surface is engageable with a substantial portion of the inner wall of the annulus fibrosus along its major and minor axes when said body assumes its said original shape after insertion into the nuclear cavity of the defective vertebral disc, whereby said implant exerts a tensile force on the inner wall of the annulus fibrosus along its major and minor axes to thereby resist hoop stresses generated by the annulus fibrosus.

39. The implant of claim 1 , wherein said exterior surface includes a top face and a bottom face, said body being sized and shaped such that said top face of said implant is engageable with a substantial portion of an end plate of the superior vertebra when said body is in its said original shape, and such that said bottom face of said implant is engageable with a substantial portion of an end plate of the inferior vertebra when said body is in its said original shape, whereby said implant inhibits further vertebral disc height collapse when said body is in its said original shape.

40. The implant of claim 1 , wherein the annulus fibrosus of the defective vertebral disc includes an opening that extends from its outer wall to its inner wall, said original shape of said body being selected so as to inhibit the expulsion of said implant through the opening in the annulus fibrosus when said body is in its said original shape, whereby said implant is retained within the nuclear cavity of the defective vertebral disc when said body is in its said original shape.

41. The implant of claim 40 , wherein said body includes a plug section extending therefrom and having a size and shape selected such that said plug section fits within the opening in the annulus fibrosus upon insertion of said body into the nuclear cavity of the defective vertebral disc.

42. The implant of claim 41 , wherein said body has a T shape.

43. The implant of claim 41 , wherein said body has a Y shape.

44. The implant of claim 41 , wherein said body has a ring shape, said body including an annular exterior member and a hollow space within said exterior member, and said plug section extending radially outwardly from said annular exterior member.

45. The implant of claim 1 , wherein said exterior surface of said body has a shape that substantially conforms to the shape of the inner wall of the annulus fibrosus.

Assignments (2)
SECURITY INTEREST Recorded Dec 23, 2020
From: MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC.
To: M&T BANK
Reel/Frame 054842/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2006
From: GERTZMAN, ARTHUR A.; MERBOTH, BARBARA L.; SCHULER, MICHAEL; STEINER, ANTON J.; SEMLER, ERIC J.; YANNARIELLO-BROWN, JUDITH I.
To: MUSCULOSKELETAL TRANSPLANT FOUNDATION
Reel/Frame 017904/0582 →